<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0002">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Anand</surname>
    <given-names>K.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ziebuhr</surname>
    <given-names>J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wadhwani</surname>
    <given-names>P.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mesters</surname>
    <given-names>J. R.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Hilgenfeld</surname>
    <given-names>R.</given-names>
   </name>
  </person-group> (
  <year>2003</year>). 
  <article-title>(3CL pro) Structure: Basis for design of Anti-SARS drugs</article-title>. 
  <source>
   <italic>Science</italic>
  </source>, 
  <volume>300</volume>(
  <issue>5626</issue>), 
  <fpage>1763</fpage>â€“
  <lpage>1767</lpage>. 
  <pub-id pub-id-type="doi">10.1126/science.1085658</pub-id>
  <pub-id pub-id-type="pmid">12746549</pub-id>
 </mixed-citation>
</ref>
